COVID-19: MACH Response

Our partners and especially our health services face unprecedented challenges over the next few months. The research response to COVID-19 is second only in importance to the clinical care challenges posed by the epidemic. The MACH has responded by helping our health services and research institutes lead the fight-back by supporting highest priority COVID-19 research. 

Please contact us with any COVID-19 queries at

MACH COVID-19 Activities

The Committee meet regularly to deploy its wide-ranging expertise to review, evaluate and endorse interventional clinical trials for MACH-affiliated health services. The Committee serves as a platform to encourage collaboration across the trials and health services where possible. 

Current Committee-endorsed trials are found below with information updated after each Committee meeting:

Factors favouring an endorsement for a trial may include:

  • Funding from the NHMRC/MRFF

  • An adaptive design

  • An opportunity to join an outstanding quality international study

  • Studies that nest in biobankable or diagnostic material

  • Studies addressing a particular local need

MACH invites partner Research Offices to alert us to studies that are sufficiently advanced to be seeking ethics and governance approval and other queries related to COVID-19 research and trials (including non-clinical trials). 


Streamlining ethical approval across MACH

Research Managers (through the statewide Hospital Research Managers Committee) have agreed to fast-track COVID-19 trials through Human Research Ethics Committee (HREC) approval and are reviewing the use of the framework of National Mutual Acceptance (NMA).

Victorian Collaborative Healthcare Recovery Initiative

Read about the Victorian Collaborative Healthcare Recovery Initiative (VCHRI),  a state-wide collaboration between MACH, Monash Partners and Western Alliance, that seeks to develop projects that contribute to the redesign and improvement of Victoria’s healthcare system during recovery from the COVID-19 pandemic through research-led innovation

Recent News & Media

COVID-19 Resources

COVID-19 Research Funding

MRFF – 2020 COVID-19 Vaccine Candidate Research grant opportunity $3 million for research to accelerate the development of promising COVID-19 prophylactic vaccine candidates for which research and development is already underway. The prophylactic vaccine must be intended to induce active long-term immunity against COVID-19. Now open - Closes 15 July MRFF – 2020 COVID-19 Immunological Studies Grant Opportunity $1 million for research that characterises the immune response across COVID-19 patients with asymptomatic, mild, moderate, severe, and critical disease. Now open - Closes 23 July MRFF - Coronavirus Research Response – 2020 COVID-19 Mental Health Research grant opportunity

$1 million for research to support research to understand how the mental health system can be enhanced to be most effective and responsive during and following the acute COVID-19 crisis. Now open - Closes 13 July

MRFF - Coronavirus Research Response - 2020 Rapid Response Digital Health Infrastructure

$4 million for digital health research infrastructure to help health systems respond faster to high-need emerging challenges. Opens 1 July - Closes 14 July

MRFF - Coronavirus Research Response - 2020 Communication Strategies and Approaches During Outbreaks

$600,000 for research to understand the community’s information needs and behavioural drivers during outbreaks, and strategies to address these. Opens 1 July - Closes 14 July


MACH is an NHMRC recognised Advanced Health Research and Translation Centre.

The mission of MACH is to improve health and wellbeing by integrating medical research, education and clinical care.


187 Grattan Street

Carlton, VIC 3053


+61 (0)3 9035 4960


MACH acknowledges the Traditional Owners of the land on which it works, the Wurundjeri People of the Kulin Nation, and pay respects to its elders past, present and emerging.

All content copyright © 2020 the Melbourne Academic Centre for Health